Concepedia

Robert O. Blaustein

RO

Statistics

Publications

36

Citations

2.1K

H-Index

21

Active since

1983

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Bayer (Germany)

University of Alberta

Canadian VIGOUR Centre

Clinical Research Institute

Robert O. Blaustein is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, biochemistry, and biophysics.

ORCID

Top concepts

Publications per year

1983–2025

36

Publications

36

[3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites.

Jonathan A. Javitch, Robert O. Blaustein, Solomon H. Snyder · Molecular Pharmacology · 1984 · 282 citations

Anthrax toxin: channel-forming activity of protective antigen in planar phospholipid bilayers.

Robert O. Blaustein, T M Koehler, R. John Collier et al. · Proceedings of the National Academy of Sciences · 1989 · 271 citations · Full text

, , +22

Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction

Paul W. Armstrong, Carolyn S.P. Lam, Kevin J. Anstrom et al. · JAMA · 2020 · 261 citations · Full text

Parasympathetic response in chick myocytes and mouse heart is controlled by SREBP

Hojin Park, S Georgescu, Chuang Du et al. · Journal of Clinical Investigation · 2008 · 168 citations · Full text

The N‐terminal half of the heavy chain of botulinum type A neurotoxin forms channels in planar phospholipid bilayers

Robert O. Blaustein, William Germann, Alan Finkelstein et al. · FEBS Letters · 1987 · 119 citations

1–5 of 36